ENABLE: ENhAncing lifestyle Behaviours in endometriaL cancEr

Not Applicable

• Conditions: Endometrial cancer; Cancer - Womb (Uterine or endometrial cancer)

• Registration Number: ACTRN12619000631101
• Lead Sponsor: Peter MacCallum Cancer Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-29
• Study Completion: 2020-06-07
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Stopped early
• Sex: Female
• Target Recruitment: 22

Inclusion Criteria

1.Women with a histologically confirmed diagnosis of endometrial cancer (EC) following surgery and scheduled for or recently commenced adjuvant therapy (brachytherapy, radiotherapy, chemotherapy or any combination of these treatments).
2.Age 18 years or above at screening
3.Have provided written informed consent for the trial
4.Able to read and write English
5.ECOG performance status of 0-2
6.Available for follow up
7.Life expectancy greater than 3 months
8.Able to access telehealth for telephone or video consultations

Exclusion Criteria

1.More than two weeks post commencement of adjuvant therapy
2.Unstable psychiatric, cognitive or substance abuse disorders that would interfere with cooperation with the requirements of the trial
3.Concurrent, actively treated other malignancy or history of other malignancy treated within the past year
4.Stage 4 or recurrent disease
5.Comorbidities preventing participation in an unsupervised walking program
6.Unable to access telehealth for video or telephone consultations
7.Met PA guidelines for the past month

Study & Design

• Study Type: Interventional
• Study Design: Not specified